U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > Funding news for global health researchers November 15, 2021 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Funding news for global health researchers November 15, 2021

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

NIDA International Forum Special Alert

2022 NIDA International Forum

Present your international drug abuse research during the 2022 NIDA International Forum, which will be held June 10-13, 2022, in Minneapolis, Minnesota.

The NIDA International Program invites abstract submissions and travel award applications from researchers around the world. Join us for the Forum research symposium, interactive workshops, poster session, and networking activities.

Application Deadline: January 16, 2022

Rockefeller Foundation Mercury Project

The Rockefeller Foundation has launched the Mercury Project to provide $10M for projects based in the United States, Africa, Asia and Latin America to support research to quantify the costs and harms of mis- and disinformation, and identify new tools to reduce its impact. The program is accepting initial letters of inquiry on a rolling basis through May 1, 2022.

NIH News

Important news from NIH for all grantees.

  • Notice of Availability of Pre-Application Webinar Recording and FAQ for RFA-MH-22-100, “Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries” (NOT-MH-22-065)

Funding Opportunities

NIH funding opportunities for which foreign organizations may apply.

  • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) (PAR-21-353)
    Application Receipt Date: November 5, 2024
  • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) (PAR-21-354)
    Application Receipt Date: November 16, 2024
  • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) (PAR-21-355)
    Application Receipt Date: November 16, 2024

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • Notice of Special Interest: Administrative Supplements for Summer Research Experiences for Students and Science Teachers (NOT-ES-22-001)
  • Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised) (NOT-HL-21-030)

Other Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of Change to Application Due Dates for PAR-21-281, “Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Clinical Trials Not Allowed)” (NOT-OD-22-020)
  • Notice of Change to Review Dates of PAR-22-054, “Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)” (NOT-RM-22-003)
  • Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trials Required)”. (NOT-CA-22-012)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R01 Clinical Trial Optional) (NOT-MH-22-020)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R21 Clinical Trial Optional) (NOT-MH-22-021)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R34 Clinical Trial Optional) (NOT-MH-22-022)

Upcoming Deadlines